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Objectives: This study was undertaken to compare conventional cardioplegic strate-
gies with a new approach that uses a modified nonpotassium maintenance solution
between cardioplegia doses in stressed neonatal hearts.
Methods: Thirty-five neonatal piglets underwent 60 minutes of ventilator hypoxia
(inspired oxygen fraction 8%-10%) followed by 20 minutes of ischemia on car-
diopulmonary bypass. In 10 animals bypass was discontinued without further
ischemia (stress control group). The other 25 received a warm blood cardioplegic
induction and were separated into 5 groups. In 5 animals cardiopulmonary bypass
was discontinued without further ischemia (cardioplegia control group); the remain-
ing 20 underwent an additional 70 minutes of cold blood cardioplegic arrest. Five
received only intermittent cardioplegia every 20 minutes, whereas 15 also received
cold blood maintenance infusions between cardioplegic doses (integrated strategy).
In 5 of these animals the blood was unmodified, whereas in 10 a modified non-
potassium “cardioplegia-like” solution was delivered either antegradely (n = 5) or
retrogradely (n = 5). Myocardial function was assessed by pressure-volume loops
(expressed as percentage of control); vascular function was assessed by coronary
vascular resistance.
Results: All piglets that underwent hypoxic ischemic stress alone (controls) died.
Warm induction alone (cardioplegic controls) partially repaired the stress injury.
Intermittent cardioplegia preserved the depressed systolic function (end-systolic
elastance 40% vs 39%), increased diastolic stiffness (255% vs 239%), reduced
adenosine triphosphate (10.6 vs 12.2 µg/g tissue), and elevated coronary vascular
resistance at levels identical to warm induction alone; infusing unmodified blood
between cardioplegia doses (standard integrated) improved results slightly. In con-
trast, infusion of a cold modified solution (antegrade or retrograde) between car-
dioplegia doses (modified integrated) completely restored systolic function
(end-systolic elastance 100% and 97%, P < .001 vs intermittent and standard inte-
grated), only minimally increased diastolic stiffness (159% and 156%, P < .001 vs
intermittent and standard integrated), restored adenosine triphosphate (18.8 and
16.6 µg/g, P < .001 vs intermittent and standard integrated), and normalized coro-
nary vascular resistance (P < .001 vs intermittent and standard integrated). This
strategy was used in 72 consecutive hypoxic patients (21 arterial switch operations,
retrograde; 51 Fontan procedures, antegrade) with a 2.8% mortality.
Conclusions: Infusion of a cold modified solution between cardioplegic doses
(modified integrated protection) significantly improved myocardial protection in
the stressed neonatal heart, was effective delivered either antegradely or retro-
gradely, and was used successfully for hypoxic (stressed) pediatric patients.
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After cardioplegic arrest, most surgeonsdeliver intermittent cardioplegia every15 to 20 minutes to maintain myocardialarrest, restore hypothermia, buffer aci-dosis, and wash away acid metabo-lites.1,2 This is traditional, but a dry field
is not always required between cardioplegic doses. To
further limit ischemia and improve protection, we intro-
duced the concept of integrated cardioplegia, which con-
sists of infusing a maintenance solution of unmodified
cold (4°C) blood between intermittent cardioplegic doses
whenever visualization is not impaired by coronary per-
fusion.1,3,4 Cold unmodified blood is used for the mainte-
nance infusions; because hypothermia alone tends to keep
the heart arrested, it allows the infusions to be safely
interrupted when a dry field is required for optimal visu-
alization, and it avoids administration of large quantities
of potassium. Despite excellent clinical results in adult
patients, the standard integrated strategy has never been
evaluated experimentally and is rarely used in pediatric
patients.1,3,4 Indeed, several studies in pediatric hearts
have suggested that multiple intermittent cardioplegic
infusions are no better, and may even be worse, than a
single cold infusion.2,5,6
Postoperative myocardial dysfunction, however, remains
the primary cause of morbidity and mortality in pediatric
patients, occurring most frequently in the presence of
cyanosis.2,6-9 Hypoxia is associated with metabolic adapta-
tions that allow normal aerobic metabolism to persist in the
resting state. However, this compensatory mechanism is
expended readily with stress, as atrial pacing or cate-
cholamine infusion causes myocardial lactate production,
indicating ischemia with a shift toward anaerobic metabo-
lism.10,11 This metabolic shift may occur in cyanotic patients
during the stresses of daily life, such as exercise, emotional
upset, and tachycardia, and may become compounded dur-
ing anoxic spells. Hypoxic hearts are also more vulnerable
to accelerated depletion of adenosine triphosphate (ATP)
during surgical ischemia, as well as predisposed toward
reoxygenation injury with the reintroduction of oxygen.5,8,12
Consequently, the cyanotic pediatric heart is more vulnera-
ble than the normoxic adult heart to inadequacies in myocar-
dial protection and might derive an even greater benefit from
an integrated approach that limits ischemia.
To parallel this experimentally, we used stressed (hypoxic
and ischemic) neonatal hearts to evaluate the conventional
techniques of intermittent cardioplegia and standard inte-
grated protection. The standard integrated strategy has the
potential problem of producing a reperfusion injury, however,
because it exposes the ischemic heart to multiple infusions of
cold unmodified blood, which Rebeyka and associates13 have
shown is dangerous in infants. We therefore also evaluated a
new approach, which replaces the cold unmodified blood
with a cold modified (nonpotassium, magnesium-enriched,
citrate-phosphate-dextrose, tromethamine) blood solution.
We termed this the “modified integrated strategy.” Use of a
modified nonpotassium “cardioplegia-like” blood solution
for the maintenance infusions has the potential advantage of
reducing any reperfusion injury, because cardioplegia limits
reperfusion damage after ischemia, and the heart is ischemic
between cardioplegic doses.1,14,15 Hyperkalemia is avoided
by not adding potassium, and the heart is kept arrested by
hypothermia as well as by changes in magnesium and cal-
cium. To more closely mimic clinical experience, we also
determined whether the method of delivery (antegrade vs ret-
rograde) affected results. This simulates operations such as
the arterial switch procedure, where antegrade perfusion is
not possible after the initial cardioplegia dose. On the basis of
the experimental infrastructure provided by these studies, we
incorporated a modified integrated strategy into our clinical
practice and examined the results in 72 high-risk patients
(Fontan and arterial switch procedures).
Methods
Thirty-five neonatal (5- to 18-day-old) piglets (3.5 to 5 kg) were
intramuscularly medicated with 40 mg/kg ketamine, were intraperi-
toneally anesthetized with 30 mg/kg phenobarbital followed by 5
mg/kg intravenously each hour, and had the lungs ventilated through
a tracheotomy with a volume ventilator (Servo 900B; Siemens/
Elema, Solna, Sweden). All animals received humane care in com-
pliance with the “Principles of Laboratory Animal Care” formulated
by the National Society for Medical Research, and “Guide for the
Care and Use of Laboratory Animals,” prepared by the National
Academy of Sciences and published by the National Institutes of
Health (NIH), Publication No. 96-03, Revised 1996. The experi-
mental preparation, including cannulation for bypass, the bypass
prime, and blood sample procurement, was comparable with that
previously described elsewhere.5,12,16
Experimental Protocols
Hypoxic-ischemic stress. All 35 piglets underwent 60 minutes
of ventilator hypoxia by lowering the fraction of inspired oxygen to
8% to 10% to produce an arterial PO2 of 25 to 35 mm Hg and an
oxygen saturation of 65% to 70%. Before hypoxemia, piglets were
transfused as necessary to increase the hematocrit to greater than
35%. This simulated the chronic adaptive change of erythrocytosis
and increased oxygen-carrying capacity, thereby allowing ischemia
to be avoided during hypoxia.5,12,16 At the end of 60 minutes,
piglets were placed on cardiopulmonary bypass (CPB) at an
inspired oxygen fraction of 100% for 5 minutes to produce a reoxy-
genation injury. The aorta was then clamped for 20 minutes at 37°C
to add a normothermic ischemic injury to the hypoxic stress.
Hypoxic-ischemic (stress) controls. Ten piglets served as con-
trols for the hypoxic-ischemic stress. Five underwent myocardial
biopsy to determine the biochemical changes; the other 5 had the
aortic clamp removed and CPB continued for 60 minutes without
further ischemia to determine the functional changes. The remain-
ing 25 piglets underwent cardioplegic arrest according to the pro-
tocol described in the next section.
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Cardioplegic administration. Cardioplegic solutions (CAPS
Service; Research Medical Inc, Salt Lake City, Utah) are shown in
Tables 1, 2, and 3. Cardioplegic solution was delivered according
to a protocol consisting of 5 minutes of warm (37°C) induction
(Table 1) followed by 4 minutes of cold multidose cardioplegia
(Table 2), a 2-minute cold multidose infusion every 20 minutes,
and a 4-minute warm (37°C) cardioplegic reperfusate (“hot shot”)
before aortic unclamping. In groups 1 through 4 all cardioplegic
infusions were delivered antegradely, whereas in group 5 the car-
dioplegic solution was delivered by a combination of antegrade
and retrograde routes. Antegrade infusions were always delivered
at a continuously measured aortic root pressure of 40 to 50 mm
Hg, and retrograde infusions were delivered at a continuously
measured coronary sinus pressure of 30 to 50 mm Hg.
Immediately after the start of cardioplegia, piglets were cooled to
a systemic temperature of 26°C, and warming to 37°C was begun
16 minutes before aortic unclamping. All piglets undergoing car-
dioplegic arrest were weaned from CPB with no inotropic support
30 minutes after aortic unclamping. After arterial blood gases, cal-
cium ion, and potassium ion were normalized, final functional and
biochemical measurements were made 30 minutes later.
Cardioplegia Groups
After the hypoxic-ischemic stress, the 25 piglets undergoing car-
dioplegic arrest received a warm induction and were divided into
5 groups. Group 1 piglets did not undergo any further ischemia,
whereas groups 2 through 5 underwent 70 minutes of cardioplegic
arrest.
Warm induction alone (group 1, cardioplegic controls). Five
piglets received warm blood cardioplegic induction and then had the
aortic crossclamp removed immediately to determine the effect of
warm induction without any further ischemia. These piglets there-
fore acted as a cardioplegic control group, because all subsequent
cardioplegia groups (groups 2-5) also received a warm induction.
Intermittent cardioplegia (group 2). To test the intermittent
cardioplegic protection strategy, 5 piglets underwent 70 minutes of
ischemic arrest with warm induction followed by cold intermittent
cardioplegia every 20 minutes and a warm reperfusate according
to the protocol detailed previously.
Integrated strategy (groups 3 through 5). During the 20-
minute intervals between cardioplegic doses, the surgeon does not
always require a dry field for optimal visualization. At these times
the heart can be perfused to reduce ischemia. To test this strategy
TABLE 1. Warm blood cardioplegia solution
Cardioplegia additive Volume added (mL) Component modified Concentration delivered*
Potassium chloride (2 mEq/mL) 10 Potassium ion 8-10 mEq/L
Tromethamine (0.3 mol/L) 225 pH pH 7.5-7.7
Citrate-phosphate-dextrose 225 Calcium ion 0.2-0.4 mmol/L
Aspartate, glutamate 250 Substrate 13 mmol/L each
50% Dextrose in water 40 Glucose <400 mg/dL
5% Dextrose in water 200 Osmolarity 380-400 mOsm
*When mixed in a 4:1 ratio with blood.
TABLE 2. Cold multidose blood cardioplegia solution
Cardioplegia additive Volume added (mL) Component modified Concentration delivered*
Potassium chloride (2 mEq/mL) 10 Potassium ion 8-10 mEq/L
Tromethamine (0.3 mol/L) 200 pH pH 7.6-7.8
Citrate-phosphate-dextrose 50 Calcium ion 0.5-0.6 mmol/L
5% Dextrose in water 1/4 isotonic saline solution 550 Osmolarity 340-360 mOsm
*When mixed in a 4:1 ratio with blood.
TABLE 3. Modified cold blood maintenance solution
Solution additive Volume added (mL) Component modified Concentration delivered*
Tromethamine (0.3 mol/L) 50 pH pH 7.5-7.6
Citrate-phosphate-dextrose 50 Calcium ion 0.5-0.6 mmol/L
Magnesium chloride (2 mEq/mL) 10 Magnesium ion 4-6 mg/L
5% Dextrose in water 1/4 isotonic saline solution 1000 Osmolarity, glucose 340-360 mOsm
Mannitol (25%) 50 Osmolarity, oxygen radical scavenger 340-360 mOsm
*When mixed in a 4:1 ratio with blood.
122 The Journal of Thoracic and Cardiovascular Surgery • January 2002
Surgery for Congenital Heart Disease Kronon et al
ED
ITO
RIA
L
CH
D
G
TS
A
CD
CH
D
CSP
TX
(integrated approach), 15 piglets received a maintenance infusion
of either unmodified blood (standard integrated strategy, group 3)
or a modified nonpotassium blood solution (modified integrated
strategy, groups 4 and 5), for the 10 minutes (half the time) imme-
diately before each intermittent cardioplegic infusion. These
piglets therefore underwent 10 minutes of ischemia followed by a
10-minute maintenance infusion and then the cardioplegia dose.
Standard integrated strategy (group 3). To test the standard
integrated myocardial protection strategy, 5 piglets received main-
tenance infusions (between cardioplegic doses) with unmodified
blood from the bypass circuit by removing the cardioplegic line
from the pump head.
Modified integrated strategy (groups 4 and 5). Unmodified
blood can potentially cause a reperfusion injury because the heart
is ischemic between cardioplegic doses and as Rebeyka showed
unmodified blood can be detrimental in infants.1,2,13,14 A modified
cardioplegia-like solution might help limit this injury. To test this
new approach, the integrated strategy was modified in 10 piglets by
infusing a cold modified nonpotassium blood maintenance solution
(Table 3) in place of unmodified blood. The method of delivery was
also evaluated, because it is not always possible to deliver ante-
grade cardioplegia (such as in the arterial switch operation).
Antegrade delivery (group 4). In 5 piglets the modified main-
tenance solution as well as all cardioplegic infusions were deliv-
ered antegradely.
Retrograde delivery (group 5). In 5 piglets retrograde delivery
was used for the cold modified maintenance infusions as well as
the intermittent cold cardioplegic doses. Warm induction and the
terminal cardioplegic reperfusate were given antegradely. This
examined the effectiveness of the modified integrated strategy for
patients in whom antegrade infusions cannot be delivered for part
of the procedure (such as those undergoing arterial switch or aor-
tic valve repair).
Myocardial Performance
Left ventricular pressure and conductance catheter signals were
amplified and digitized to inscribe left ventricular pressure-
volume loops after first correcting for parallel conductance
(myocardial tissue and blood viscosity) with hypertonic saline
solution as previously described.5,16 Measurements were made
before hypoxia (baseline) and 30 minutes after CPB was discontin-
ued. The end-systolic and end-diastolic pressure-volume relation-
ship and preload recruitable stroke were analyzed with the use of a
computer graphics program (Spectrum; Bowman-Gray School of
Medicine, Winston-Salem, NC), as previously described.5,12,16
Functional measurements are expressed as percentage recovery of
baseline values, with each piglet acting as its own control. After
final hemodynamic measurements, all piglets were placed back on
bypass, and transmural left ventricular biopsy specimens were
obtained for biochemical analysis, with a separate sample obtained
for myocardial water determination as previously described.
Physiologic Measurements
Coronary vascular resistance (CVR) was determined during each
antegrade cardioplegic infusion by measuring coronary sinus pres-
sure and cardioplegic flow once a constant infusion rate with an
aortic root pressure between 40 and 50 mm Hg was achieved.
CVR was calculated as previously described as the change in pres-
sure across the coronary vascular bed divided by the cardioplegia
flow rate, multiplied by 80, and expressed as dynes · s · cm–5.5,16
Myocardial Oxygen Consumption
Blood was obtained at 1-minute intervals from the cardioplegia
line and coronary sinus across the 4 minutes of warm reperfusion
(hot shot, groups 2-5), and myocardial oxygen consumption was
determined as previously described elsewhere.17 The cumulative
myocardial oxygen consumption was determined by the sum of
the individual 1-minute values and expressed per 100 g of heart
tissue, which was determined by weighing the left ventricle at the
conclusion of the experiment.
Biochemical Analysis
Adenosine pool. Myocardial samples were crushed in a liquid
nitrogen–cooled mortar and pestle and lyophilized (Savant Speed
Vac Systems, Farmingdale, NY). The adenosine pool was deter-
mined as described previously, and ATP levels were expressed as
micrograms per gram dry tissue.5,16
Myeloperoxidase activity. Quantitative myeloperoxidase activ-
ity was determined as described previously and is expressed as the
change in optical density units per minute per milligram of tissue
protein (∆OD · min–1 · mg–1 protein).17
Antioxidant reserve capacity. Myocardial antioxidant reserve
capacity (AORC) was assessed as previously described by deter-
mining the in vitro lipid peroxidation in cardiac tissue that was
homogenized and incubated with t-butylhydroperoxide at a con-
centration of 4 mmol/L.12 AORC was expressed as malondialde-
hyde production in nanomoles per gram of heart tissue protein.
The higher the production of malondialdehyde to the oxidant
stress (t-butylhydroperoxide), the lower the tissue AORC, indicat-
ing depletion of antioxidants secondary to exposure of the heart to
oxygen-derived free radicals during reperfusion.
Conjugated diene production. Blood was obtained from the car-
dioplegia line and coronary sinus 1 and 4 minutes after starting warm
reperfusion (hot shot) in groups 2 through 5, and conjugated dienes
were assessed as previously described elsewhere.17 Conjugated diene
production was expressed per 100 g of heart tissue by weighing the
left ventricle at the conclusion of the experiment.
Myocardial water. Ventricular samples were placed in pre-
weighed vials and dried to a constant weight at a temperature of
85°C. The percentage of myocardial water was calculated accord-
ing to the following formula: percentage of myocardial water =
[(wet weight – dry weight)/wet weight] × 100%.
Clinical Studies
The charts of all neonates undergoing an arterial switch operation
within the first month of life and of infants undergoing a modified
lateral-tunnel Fontan procedure at the University of Illinois or The
Heart Institute for Children from July 1, 1996, to December 31,
1998, were retrospectively reviewed. The starting date was chosen
because this is when we began to use a modified integrated strategy
when applicable in adult and pediatric patients. The clinical car-
dioplegia protocol consisted of cold induction, followed by cold
multidose infusions every 10 to 15 minutes, and finally a substrate-
enriched terminal warm reperfusate before removal of the aortic
crossclamp. A cold modified (nonpotassium) blood maintenance
solution was infused continuously whenever it did not impair opti-
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mal visualization. In Fontan procedures, all infusions were given in
an antegrade fashion. In arterial switch operations, the cardioplegic
induction was delivered antegradely. Thereafter, all cold intermit-
tent cardioplegia and maintenance (modified solution) infusions
were delivered retrogradely, because antegrade delivery is impossi-
ble with the aorta divided. However, all patients undergoing arter-
ial switch received an antegrade (terminal) warm blood
cardioplegic reperfusate before removal of the aortic crossclamp.
Statistics
Data were analyzed with JMP V2.0 (SAS Institute, Inc, Cary, NC)
on a Macintosh IIVX computer (Apple Computer, Inc, Cupertino,
Calif). Paired Student t tests with 1-way analysis of variance were
used for comparison of variables among experimental groups. If
the analysis of variance revealed a significant interaction, pairwise
tests of individual group means were compared by means of mul-
tiple comparisons (Tukey test) at significance levels of P < .05, P
< .01, and P < .001. Group data are expressed as mean ± SEM.
Results
There was no statistically significant difference (P > .2)
between groups for baseline (prehypoxic) values (slopes) of
left ventricular contractility (end-systolic elastance 35 ± 2
mm Hg/mL), diastolic compliance (0.04 ± 0.01), or preload
recruitable stroke work (68 ± 3 ∫[mm Hg · mL]/mL).
Hemodynamic and Physiologic Measurements
Results are depicted in Figures 1 through 4. There were no
significant changes or differences (P > .2) in the x-axis
intercept (V0) for end-systolic elastance or preload
recruitable stoke work between prebypass (baseline) and
postbypass values in any cardioplegic group. Therefore, the
change in slope of end-systolic elastance and preload
recruitable stroke work could be interpreted to represent
variability in the contractile state of the myocardium rela-
tive to baseline values. This also allowed the change in
Figure 1. Postbypass left ventricular contractile function after 70-
minute cardioplegic arrest. Recovery of left ventricular systolic
function as measured by end-systolic elastance (EES) and
expressed as percentage of control (baseline). Exposing the heart
to hypoxia and ischemia produced such severe stress that warm
induction blood cardioplegia was only able to partially resuscitate
the heart. Intermittent cardioplegia preserved function at these
same levels despite addition of 70 minutes of ischemic arrest. In
contrast, adding maintenance infusions of unmodified cold blood
(standard integrated strategy) further resuscitated the heart and
improved contractility. However, this effect was maximized if mod-
ified solution was used for the maintenance infusions (modified
integrated strategy), resulting in complete return of systolic func-
tion. Asterisk indicates P < .001 versus intermittent cardioplegia;
double asterisk indicates P < .001 versus all other groups.
Figure 2. Postbypass left ventricular diastolic compliance after
70-minute cardioplegic arrest, as measured by end-diastolic pres-
sure volume relationship and expressed as percentage of stiff-
ness compared with control (baseline). Asterisk indicates P < .001
versus intermittent cardioplegia; double asterisk indicates P <
.001 versus all other groups.
Figure 3. Recovery of overall myocardial function as measured by
preload recruitable stroke work (PRSW) and expressed as per-
centage of control (baseline). Asterisk indicates P < .001 versus
intermittent cardioplegia; double asterisk indicates P < .001 ver-
sus all other groups.
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slope to be expressed as a percentage of baseline, with each
piglet acting as its own control. The combination of hypoxia
and ischemia caused such a severe injury that bypass could
not be discontinued in piglets not receiving cardioplegia
(hypoxic-ischemic controls), despite an additional 60 min-
utes of CPB support. Thus no postbypass functional mea-
surements could be obtained in these piglets. In contrast,
warm induction without ischemia (group 1, cardioplegic
controls) partially resuscitated the hypoxic-ischemic
myocardium, thereby allowing bypass to be discontinued.
However, these piglets still had depressed postbypass sys-
tolic contractility (end-systolic elastance 39% ± 3%),
markedly increased diastolic stiffness (271% ± 8%), and
reduced preload recruitable stroke work (40% ± 2%).
Adding 70 minutes of cardioplegic ischemia with multidose
cold intermittent cardioplegic infusions (group 2) preserved
but did not improve myocardial function, as it was identical
(P > .2) to hearts receiving warm cardioplegia without fur-
ther ischemia (group 1). In contrast, postbypass function
was slightly improved if a maintenance solution of cold
unmodified blood (standard integrated protection) was
given for 10 minutes between intermittent cardioplegic
infusions (group 3). However, there was complete func-
tional recovery if the maintenance infusions used a modi-
fied nonpotassium blood solution (modified integrated
strategy). These improved results were independent of
whether the modified solution was infused antegradely
(group 4) or retrogradely (group 5). CVR followed a simi-
lar trend. The CVR decreased to normal when the heart was
protected with a modified integrated strategy, delivered
either antegradely or retrogradely (groups 4 and 5).5,16
Piglets that received retrograde delivery (group 5), however,
only had CVR determined during warm induction and
reperfusion, because CVR measurements were made during
antegrade infusions. In contrast, the CVR remained ele-
vated in groups 2 (intermittent) and 3 (standard integrated
strategy), although there was a slight improvement
(decrease) in piglets receiving maintenance infusions of
unmodified blood (standard integrated strategy).
Biochemical Studies
Results are summarized in Table 4. Compared with levels at
the end of the hypoxic-ischemic stress, warm blood cardio-
plegia induction alone (group 1) improved the biochemical
markers of injury. However, there was still a significant oxi-
dant injury, as documented by the decreased tissue AORC.
The myeloperoxidase activity was increased, and the ratio
of ATP to adenosine diphosphate (ADP), which measures
the ability of the mitochondria to phosphorylate ADP to
ATP and is an indirect measurement of mitochondrial func-
tion, was decreased. Intermittent cold blood cardioplegia
maintained energy levels (ATP) and mitochondrial function
(ATP/ADP ratio) and prevented a further oxidant injury (no
change in AORC), despite an additional 70 minutes of
ischemia. Mitochondrial dysfunction (low ATP/ADP ratio)
prevented replenishment of ATP levels and probably
explains the lower oxygen uptake during reperfusion. In
contrast, infusion of unmodified cold blood between car-
dioplegia infusions (standard integrated strategy) partially
improved all metabolic markers. By reducing the oxidant
injury, mitochondrial function was partially restored
(improved ATP/ADP ratio), which allowed ATP levels to be
increased, resulting in higher oxygen uptake during reper-
fusion. However, infusion of a maintenance solution of
modified nonpotassium blood between cardioplegia doses
(modified integrated strategy) completely resuscitated the
heart, preventing oxidant injury (lower conjugated dienes)
and restoring AORC, mitochondrial function (ATP/ADP
ratio), and energy levels (ATP). As with the functional data,
the method of delivery was unimportant, because there were
no differences between antegrade and retrograde infusions.
The myocardial water (edema) and myeloperoxidase activ-
ity, which are both indirect measurements of cellular injury,
were also reduced with a modified integrated strategy
(groups 4 and 5), further supporting decreased cellular dam-
age in these hearts.
Figure 4. CVR measured during each antegrade cardioplegic infu-
sion. Piglets receiving retrograde delivery of modified solution
(group 5) only had CVR measured during warm induction and
reperfusion, and these values were not different from those of
piglets receiving antegrade infusions (group 4). Solid line depicts
CVR in 6 normal (nonstressed) piglets subjected to 70 minutes of
cardioplegic arrest with same cardioplegic protocol (warm induc-
tion, multidose cold intermittent cardioplegia, and warm reperfu-
sion). This line therefore represents normal CVR with no vascular
dysfunction from stress (hypoxic) injury. After hypoxic-ischemic
stress, CVR is increased and remains high with intermittent car-
dioplegia alone, suggesting vascular injury. However, CVR
declines toward normal if maintenance infusions are delivered
between cardioplegic doses (integrated strategy), and this effect
is maximized if modified solution is used for infusions (see text for
details). Data points represent mean; error bars represent SE.
Single asterisk indicates P < .001 versus all other groups.
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Clinical Studies
There were 72 patients, 51 undergoing a Fontan operation
and 21 an arterial switch procedure. The overall mortality
was 2.8% (2/72), with 1 death in each group. In the Fontan
group the mean age was 40 ± 7 months (range 7-219
months), and the preoperative diagnoses were diverse.
Fifteen patients had undergone a previous Norwood proce-
dure, and 27 had undergone a bidirectional Glenn shunt.
Among patients undergoing an arterial switch operation, the
mean age was 7 ± 1 days (range 2-24 days), and all had the
diagnosis of dextro-transposition, 4 with a ventricular sep-
tal defect. The bypass, crossclamp, and ischemic times, as
well as postoperative length of stay and mortality, are listed
in Table 5.
Discussion
With an in vivo, clinically applicable animal model, this
study demonstrates (1) that the conventional techniques of
intermittent multidose blood cardioplegia alone or with
maintenance infusions of cold unmodified blood (standard
integrated strategy) provides inadequate protection of the
stressed (hypoxic-ischemic) neonatal heart, (2) that infusion
of a cold modified nonpotassium maintenance blood solu-
tion between intermittent cardioplegia doses (modified inte-
grated strategy) completely resuscitates the stressed
neonatal heart, restoring myocardial, metabolic, and vascu-
lar function, (3) that the modified solution is equally effec-
tive delivered in an antegrade or retrograde fashion, and (4)
that this method has been applied successfully to 72
hypoxic (stressed) pediatric patients, with excellent results.
Chronically hypoxic (cyanotic) patients have reduced
ATP levels secondary to ischemic insults during times of
TABLE 4. Myocardial oxygen consumption and biochemical results
Myocardial
Conjugated
oxygen
diene production*
AORC† Myeloperoxidase
consumption*
(OD/[mL · 100 g · min)
malondialdehyde ATP (µg/g ATP/ADP Myocardial (∆OD/[min · 
Group (mL/100 g/4 min) 1 min 4 min (nm/g protein) dry weight) ratio water (%) mg protein])
Hypoxic-ischemic — — — 1441 ± 24 8.2 ± 0.3 1.1 ± 0.2 80.1 ± 0.1 2.4 ± 0.2
stress (n = 5)
Warm induction alone — — — 1229 ± 22‡ 10.7 ± 0.2‡ 1.8 ± 0.1‡ 80.8 ± 0.1‡ 1.9 ± 0.1‡
(group 1, n = 5)
Intermittent 4.3 ± 0.3 57 ± 2 60 ± 1 1216 ± 26‡ 10.8 ± 0.4‡ 2.0 ± 0.2‡ 80.7 ± 0.1‡ 1.8 ± 0.1‡
cardioplegia
(group 2, n = 5)
Standard integrated 6.5 ± 0.1§ 37 ± 1§ 40 ± 2§ 1045 ± 20 13.6 ± 0.3 2.9 ± 0.2 80.2 ± 0.1 1.3 ± 0.1
strategy (group 3,
n = 5)
Modified integrated 8.4 ± 0.2¶ 17 ± 2¶ 19 ± 2¶ 861 ± 18¶ 16.4 ± 0.5¶ 3.7 ± 0.2¶ 79.5 ± 0.1¶ 0.8 ± 0.2¶
strategy, antegrade
(group 4, n = 5)
Modified integrated 8.6 ± 0.2¶ 18 ± 1¶ 20 ± 2¶ 874 ± 16¶ 16.5 ± 0.4¶ 3.9 ± 0.2¶ 79.4 ± 0.2¶ 0.9 ± 0.1¶
strategy, retrograde
(group 5, n = 5)
F 179 305 315 238 162 71.4 35.6 52
P value <.001 <.001 <.001 <.001 <.001 <.001 <.001 <.001
*During warm cardioplegic reperfusion (“hot shot”).
†Malondialdehyde production at 4-mmol/L t-butylhydroperoxide.
‡P < .001 versus hypoxic-ischemic stress.
§P < .001 versus group 2.
P < .001 versus groups 1 and 2.
¶P < .001 versus groups 1, 2, and 3.
TABLE 5. Postoperative clinical results
Variable Fontan (n = 51) Arterial switch (n = 21)
Bypass time (min) 164 ± 7 (88-274) 204 ± 9 (151-304)
Crosscamp time (min) 98 ± 5 (43-200) 102 ± 4 (79-141)
Ischemic time (min) 24 ± 4 (2-95) 27 ± 3 (10-65)
Postoperative stay (d) 8.4 ± 0.5 (5-18) 10.6 ± 1.1 (5-27)
Mortality 1/51 (2%) 1/21 (4.7%)
Ischemic time represents time that the crossclamp is on and there is no
myocardial perfusion (neither antegrade nor retrograde).
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increased stress (eg, tachycardia, exercise).2,6-8,10,11 To sim-
ulate the cyanotic child undergoing operative repair, piglets
therefore underwent both hypoxic and ischemic stress.
Although an acute stress does not exactly mimic chronic
hypoxia, several studies have demonstrated similar changes
with reoxygenation of acutely hypoxic piglets and chroni-
cally hypoxic infants.12,18-23 In addition, despite the absence
of adaptation, we characterized almost identical changes in
21 cyanotic infants with the same biochemical tests as those
used in our acute experimental studies.20 It is important to
use stressed (hypoxic-ischemic) hearts when investigating
cardioplegic strategies, because they are more sensitive to
changes in protection.1,5,8,9,16,17,20 Consequently, our model
provides information about the patients most vulnerable to
postoperative dysfunction. This approach parallels the evo-
lution of cardioplegia strategies in adults, where acute
ischemia has been used to mimic the chronic clinical condi-
tions of angina and cardiogenic shock.1
The hypoxic-ischemic stress produced a significant oxy-
gen-derived free radical–mediated injury, resulting in cellu-
lar damage that was so severe that CPB could not be
discontinued. However, warm induction was able to partially
resuscitate the hypoxic-ischemic neonatal heart, and despite
the addition of 70 minutes of ischemic arrest, intermittent
infusions of cold blood cardioplegia preserved hemody-
namic and metabolic function at levels identical to warm
induction without further ischemia. Intermittent cardioplegia
therefore effectively prevents any further myocardial dam-
age, but is unable to improve the stress injury. Conversely,
infusion of a maintenance solution of unmodified blood
between intermittent cardioplegic infusions (standard inte-
grated strategy) improved functional and metabolic recov-
ery. However, this effect was maximized only if a modified
(nonpotassium) blood solution was used for the maintenance
infusions. This improvement was independent of the method
of delivery, with antegrade and retrograde infusions result-
ing in similar recoveries. This implies that maintenance infu-
sions of a cold modified solution do more than just limit
ischemia during cardioplegic arrest, they also actively resusci-
tate the stressed heart, because a modified solution improved
functional and metabolic recovery relative to piglets receiving
warm induction without ischemia. This conclusion is further
supported by the finding that a modified maintenance solution
(modified integrated strategy) improved recovery to a greater
extent than continuous infusions of unmodified blood (stan-
dard integrated strategy), despite the fact that both these
approaches reduce ischemia equally by providing oxygenated
blood during myocardial arrest.
Previously only warm blood cardioplegia has been
demonstrated to have the ability to resuscitate the stressed
heart.1,4 Normothermia is thought to be necessary to opti-
mize the enzymatic reactions needed for cellular repair.
Why such a dramatic improvement occurs when a modified
maintenance solution is infused at 4°C is unknown, but it
suggests that the solution is working through a mechanism
that is not dependent on enzymatic activity. It is possible
that the same effect would have occurred if the modified
solution had been infused under normothermic conditions.
Keeping the heart warm is potentially dangerous, however,
because it is less tolerant to ischemic intervals when the
infusion are interrupted or if cardioplegic distribution is not
adequate to all myocardial segments. Maintenance infu-
sions were given for only half the time between cardio-
plegic infusions, to mimic the clinical situation in which
infusions must occasionally be interrupted to optimize visu-
alization needed for surgical repair. The maintenance infu-
sions were always delivered at a measured pressure of 30 to
50 mm Hg, because infusion of intermittent cardioplegia at
higher pressures (>80 mm Hg) is detrimental to stressed
neonatal hearts.24 These lower pressures (30-50 mm Hg)
are probably even more important with continuous delivery,
because the heart is exposed to this pressure for a prolonged
period. The modified solution used for the maintenance
infusions was based on our multidose cardioplegia solution,
but the potassium was removed to avoid postbypass hyper-
kalemia.1 Furthermore, potassium is probably not required,
because the cold arrested heart tends to stay that way if it is
maintained at 4°C.1,4 To ensure myocardial quiescence,
however, potassium cardioplegia is still given every 20 min-
utes, or whenever the continuous infusions are interrupted,
because the arrested heart can have small-amplitude ven-
tricular fibrillation develop; this is not always visible but
still results in increased oxygen consumption and
ischemia.1,25 Whether any particular component in the
modified solution is more important is unknown. Because
each component was found to be important in multidose
cardioplegic solutions, however, the same is probably true
of the modified solution.
CVR was measured with each cardioplegic infusion to
determine the effects of each strategy on vascular function.
Vascular dysfunction can adversely affect myocardial pro-
tection by altering cardioplegic distribution. The coronary
vasculature normally vasodilates after ischemia, resulting in
a decrease in CVR. The CVR should therefore be reduced
after the 20-minute ischemic stress, as well as between
intermittent cardioplegic doses. However, the CVR was
increased with warm induction and remained elevated with
each intermittent cardioplegic infusion. This implies vascu-
lar dysfunction as a result of a vascular injury, as well as
that this injury persists throughout the period of cardio-
plegic arrest. In contrast, the CVR progressively decreased
with each cardioplegic infusion in hearts receiving inte-
grated protection. This improvement was greatest in the
group receiving maintenance infusions of a nonpotassium
modified blood solution (modified integrated strategy).
These infusions, however, should have had the opposite
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effect, because they reduce ischemia between cardioplegic
doses so that the coronary vasculature should not need to
vasodilate. This decrease in CVR therefore implies progres-
sive repair of a vascular injury with normalization of vascu-
lar function. We cannot be certain that the normalization of
CVR indicates repair of the vascular injury, because spe-
cific test of vascular function were not done after bypass.
That is the most likely explanation, however, because CVR
directly correlates with functional and metabolic recovery.
On the basis of these experimental results, we began
using a modified integrated strategy whenever possible in
both adult and pediatric patients, because this concept
should be independent of age. We chose patients undergo-
ing a Fontan or arterial switch procedure for this retrospec-
tive review only because these patients all received this
method of protection. These two groups also allowed us to
evaluate different methods of delivery and age groups,
because the patients undergoing Fontan procedures were
older and received antegrade delivery, whereas those under-
going arterial switch operations were neonates and received
retrograde delivery. As in the experimental studies, the
maintenance infusions were occasionally interrupted.
However, they were only stopped when visualization was
problematic, such as when working around the coronary
sinus in Fontan procedures or the left main coronary artery
in arterial switch operations. Despite the high-risk nature of
these two groups, the results were excellent and support the
clinical application and safety of this approach.
Relative to antegrade delivery, retrograde delivery pro-
vides superior perfusion of the vulnerable left ventricular
subendocardium and septum, especially in the setting of
coronary occlusion or ventricular hypertrophy.1,26-28 This
study suggests that another reason to use retrograde cardio-
plegia is to provide cardioplegic delivery whenever frequent
antegrade infusions are not possible (such as with arterial
switch procedures). In contrast to adults, however, protec-
tion of the right ventricle is often more important in pedi-
atric patients because of the frequent problems of right
ventricular hypertrophy and postoperative pulmonary
hypertension.2,6 The pediatric surgeon must therefore be
careful about relying solely on retrograde delivery, because
it may not supply adequate nutritive flow to the right ven-
tricular free wall, especially at normothermia.26-28 This was
the reason that the terminal warm reperfusate (hot shot) was
always delivered antegrade, because this helps to compen-
sate for any inadequacies in right ventricular free wall pro-
tection by repairing cellular damage that may have occurred
during cold cardioplegic arrest.
In summary, this study demonstrated the advantages of
infusing a modified (nonpotassium) blood maintenance
solution whenever possible, not only to limit ischemia but
to help resuscitate the damaged (stressed) heart, thus
improving postoperative myocardial, metabolic, and vascu-
lar function. These infusions are equally effective whether
delivered in an antegrade or retrograde fashion and have
been used successfully for high-risk patients. Because the
stressed (hypoxic) heart is more sensitive to ischemia as
well as more predisposed toward post myocardial dysfunc-
tion, surgeons should consider incorporating a modified
integrated strategy into their clinical practice.2,6-9
We acknowledge Dr Gerald D. Buckberg for his collaboration
and consultation, Ms Katherine Tubeszewski, RN, MSN, for her
help with clinical data collection, and the organizational and sec-
retarial assistance of Ms Tina Green.
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Discussion
Dr David Clarke (Denver, Colo). Congratulations to Allen and
colleagues for a meticulous and obviously carefully constructed
experimental study and some obviously superb clinical results.
I would like to address three areas. The first involves the induc-
tion of the ischemic stress before the cardioplegic protection. You
seem to have gone to a great deal of effort to simulate the clinical
situation by limiting your continuous infusion to only half the
period to allow time for possibly complex portions of the repair.
Yet at the beginning of your protocol you subjected the hearts to
20 minutes of unprotected warm ischemia, which is something
that I at least try to avoid in the clinical situation. Perhaps you
could comment on the rationale for this approach.
Dr Allen. The hypoxic ischemic stress was our way of simu-
lating a cyanotic (hypoxic) infant undergoing operative repair. We
first subjected the piglets to 1 hour of hypoxia. However, our
model of acute hypoxia does not result in any ischemia or ATP
depletion, whereas most cyanotic children have reduced ATP lev-
els at the time of surgery as a result of ischemic insults during
times of increased stress (eg, tachycardia and exercise). We there-
fore added a 20-minute ischemic insult to more closely simulate
the chronically hypoxic (cyanotic) patient. We recognize that this
acute stress (hypoxia-ischemia) does not exactly mimic the chron-
ically hypoxic (cyanotic) child. However, several studies have
demonstrated similar changes after reoxygenation of the chroni-
cally hypoxic infant, and we recently documented an identical
injury in 21 cyanotic infants with the same biochemical tests as
those used in our acute experimental studies. It is important to test
cardioplegic protocols in stressed (hypoxic) hearts, because they
are more sensitive to changes in myocardial protection and are the
most vulnerable to postoperative dysfunction. This is why adult
studies usually subject the heart to an acute ischemic stress by
crossclamping the aorta, even though this does not exactly mimic
the clinical conditions of chronic ischemia or heart failure.
Dr Clarke. The next issue involves the flows and volumes that
were used in the administration of the various solutions. In your
article you indicated that you tried to maintain certain pressures in
the aortic root and certain pressures in the coronary sinus, and you
also indicated the durations of these infusions of the warm cardio-
plegia, the cold cardioplegia, and your modified solution. I could
probably do the math, because you did mention CVR, but I would
really appreciate it if you would tell me how much volume this
requires and give your flow rates. I have tried in the operating
room to give antegrade cardioplegia continuously on numerous
occasions at low flow rates and found that it is almost impossible
to keep the aortic valve closed, and the cardioplegic solution there-
fore runs off in the ventricular vent. With higher flows, it would
seem to me that you would have a great deal of difficulty doing
some of your more complex transatrial repairs, such as atrioven-
tricular septal defect or transatrial tetralogy repairs. Would you
like to comment on this?
Dr Allen. We usually do not measure cardioplegia volumes but
deliver cardioplegic solution at a given pressure (30-50 mm Hg)
across a specific time interval, because oxygen and nutrients are
taken up with time, not by a specific dose. In these studies this usu-
ally resulted in a flow rate into the aorta or coronary sinus of around
50 mL/min. I believe that it is important to always measure the car-
dioplegic infusion pressure, because high pressures can be detri-
mental, especially to hypoxic tissue, whereas low pressures signify
inadequate delivery. A low infusion pressure is often due to a tech-
nical problem. If the cardioplegic delivery pressure remains low
despite adequate flows, the surgeon should first try to correct the
underlying cause. Simply giving a set volume that is inadequately
delivered yields a false sense of security that the cardioplegic solu-
tion is protecting the heart. In cases of severe aortic insufficiency, I
would not persist in trying to keep the aortic valve closed and the
pressure adequate. In these cases I would either open the aorta and
give cardioplegic soltuion directly into the coronary arteries or
switch to retrograde delivery. Finally, continuous infusions should
only be given when they do not impair visualization. During these
times, we rely on intermittent cardioplegia alone.
Dr Clarke. My last question is somewhat related. At the flows
that I believe are required to maintain the pressures that you indi-
cated, you are probably giving a larger amount of solution. I have
used continuous retrograde cardioplegia for a number of years at 1
mL · kg–1 · min–1 and have not really had serious problems with
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hyperkalemia. It seems to me that what you are doing here is a
combination of potassium cardioplegia and magnesium cardiople-
gia. I wonder whether there is a significant advantage to having
hypermagnesemia in the early postoperative period as opposed to
hyperkalemia. Perhaps you can comment on this. Have you mea-
sured magnesium levels in the experimental situation or in the
clinical situation?
Dr Allen. Yes, we have used a modified integrated strategy
with this type of solution clinically for several years in both adult
and pediatric patients. We also currently add magnesium to our
intermittent cardioplegic infusions. To the best of my knowledge
we have not had a problem with high postoperative magnesium
levels, and Hearse* has shown that cardioplegic solutions with
magnesium levels as high as 16 mEq/L are safe. We use a magne-
sium-free bypass prime, and several studies have shown that there
is depletion of intracellular magnesium with initiation of CPB, as
well as during cardioplegic arrest. In some respects what we are
doing by adding magnesium to the cardioplegic and maintenance
solutions is restoring the intracellular magnesium that would nor-
mally be depleted by CPB. An increased magnesium level should
not be problematic, because it prevents arrhythmias, and any
adverse myocardial effects can easily be reversed with calcium.
For this reason, we believe it is extremely important to normalize
ionic calcium levels in the upper range of normal before discon-
tinuing bypass, especially if a patient receives a large amount of
cardioplegic solution.
Dr John Hawkins (Salt Lake City, Utah). Were your study ani-
mals perfused at normothermia or hypothermia?
Dr Allen. The temperature was reduced to 25°C immediately
on initiation of CPB, and the piglets were rewarmed about 16 min-
utes before removal of the aortic crossclamp. We began rewarming
the animals approximately 12 minutes before the terminal warm
reperfusate.
Dr Hawkins. So the body temperature was kept cold the whole
time.
Dr Allen. Correct.
Dr Hawkins. With intermittent cardioplegia you do get some
myocardial warming if the body temperature is warm, and I won-
der what role that simple cooling had in this. In other words, the
continuous infusion simply kept the heart colder and may not have
much to do with the mixture versus intermittent cardioplegia with
a body temperature that was somewhat warm.
Dr Allen. No, this does not explain the findings. When we gave
a warm induction and then removed the aortic clamp, there was only
40% recovery of overall myocardial function, despite no cardioplegic
ischemia. Furthermore, recovery was still not complete when we
infused cold unmodified blood between cardioplegic infusions (stan-
dard integrated), despite the fact that the heart was kept cold and per-
fused with an oxygenated solution. In contrast, there was complete
recovery if a cold modified solution was used for the maintenance
infusions. Thus, neither temperature nor oxygen alone explains our
results. Instead, by some unknown mechanism a cold modified solu-
tion allows the heart to repair the hypoxic-ischemic stress.
* Hearse DJ, Stewart DA, Braimbridge MV. Myocardial protection during
ischemic cardiac arrest: the importance of magnesium in cardioplegic
infusates. J Thorac Cardiovasc Surg. 1978;75:877-85.
